Literature DB >> 27621490

Identification of Patients Eligible for IV-to-PO Conversion: A Cost-Minimization Study.

Merisa Mok1, Angus Kinkade2, Anthony Tung3, Aaron M Tejani4.   

Abstract

Entities:  

Year:  2016        PMID： 27621490      PMCID： PMC5008426          DOI： 10.4212/cjhp.v69i4.1584

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  10 in total

1.  Implementing a program for switching from i.v. to oral antimicrobial therapy.

Authors:  A Wong-Beringer; K H Nguyen; J Razeghi
Journal:  Am J Health Syst Pharm       Date:  2001-06-15       Impact factor: 2.637

2.  Use of a physician order entry system to identify opportunities for intravenous to oral levofloxacin conversion.

Authors:  I Glemaud
Journal:  Am J Health Syst Pharm       Date:  2000-11-15       Impact factor: 2.637

Review 3.  Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients.

Authors:  Lizanne Béïque; Rosemary Zvonar
Journal:  Can J Hosp Pharm       Date:  2015 Jul-Aug

4.  Budget impact analysis of conversion from intravenous to oral medication when clinically eligible for oral intake.

Authors:  Brandyn D Lau; Brian L Pinto; David R Thiemann; Christoph U Lehmann
Journal:  Clin Ther       Date:  2011-10-15       Impact factor: 3.393

Review 5.  Clinical and economic impact of intravenous to oral conversion therapy programs.

Authors:  Michelle C Nadeau; Effie L Kuti
Journal:  Conn Med       Date:  2011-01

6.  Correlates and Economic and Clinical Outcomes of an Adult IV to PO Antimicrobial Conversion Program at an Academic Medical Center in Midwest United States.

Authors:  Rory Sallach-Ruma; Jennifer Nieman; Jayashri Sankaranarayanan; Tom Reardon
Journal:  J Pharm Pract       Date:  2014-01-07

7.  An information system to promote intravenous-to-oral medication conversion.

Authors:  J M Teich; A M Petronzio; J R Gerner; D L Seger; C Shek; J Fanikos
Journal:  Proc AMIA Symp       Date:  1999

8.  Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oral.

Authors:  Joseph L Kuti; Thuy N Le; Charles H Nightingale; David P Nicolau; Richard Quintiliani
Journal:  Am J Health Syst Pharm       Date:  2002-11-15       Impact factor: 2.637

9.  Conversion from intravenous to oral medications: assessment of a computerized intervention for hospitalized patients.

Authors:  Michael A Fischer; Daniel H Solomon; Jonathan M Teich; Jerry Avorn
Journal:  Arch Intern Med       Date:  2003-11-24

10.  The impact of a pharmacist-managed dosage form conversion service on ciprofloxacin usage at a major Canadian teaching hospital: a pre- and post-intervention study.

Authors:  Bradley P Ho; Tim T Y Lau; Robert M Balen; Terryn L Naumann; Peter J Jewesson
Journal:  BMC Health Serv Res       Date:  2005-06-29       Impact factor: 2.655
  10 in total
  3 in total

1.  Assessment of Intravenous versus Oral Antimicrobials in a Large Regional Health Authority.

Authors:  Manpreet Dulku; Tina Sekhon; Aaron M Tejani
Journal:  Can J Hosp Pharm       Date:  2022-04-04

2.  Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies.

Authors:  Julie Downen; Cassie Jaeger
Journal:  BMJ Open Qual       Date:  2020-01

3.  Short and Concise Peer-to-Peer Teaching-Example of a Successful Antibiotic Stewardship Intervention to Increase Iv to Po Conversion.

Authors:  Johannes Wild; Bettina Siegrist; Lukas Hobohm; Thomas Münzel; Thomas Schwanz; Ingo Sagoschen
Journal:  Antibiotics (Basel)       Date:  2022-03-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.